Table 4 |
|||
| Diagnostic odds ratio (dOR) calculated for each immunohistochemistry marker or combination | |||
| IHC ANALYSIS | dOR (95% CI) | Q | P |
| CK-19 [10,14-33] | 14.73 (8.20-26.45) | 110.05 | <0.00001 |
| GAL-3 [10,14-17,19,21,25-56] | 23.41 (14.02-39.07) | 252.72 | <0.00001 |
| HBME-1 [10,14-19,21,24-27,29,30,41,51,57-61] | 40.97 (21.42-78.37) | 140.82 | <0.00001 |
| CK-19 + HBME-1 [14,17] | 119.06 (6.81-2080.37) | 2.62 | 0.1058 |
| GAL-3 + CK-19 [14,17] | 86.54 (10.8-693.52) | 2.89 | 0.8292 |
| GAL-3 + HBME-1 [14,17,46,51] | 21.94 (2.88-167.49) | 21.16 | 0.0001 |
| GAL-3 + HBME-1 + CK-19 [14,17,29] | 95.06 (25.17-359.08) | 2.23 | 0.3280 |
de Matos et al. Diagnostic Pathology 2012 7:97 doi:10.1186/1746-1596-7-97
